RAM
TGTX icon

Riggs Asset Management’s TG Therapeutics TGTX Stock Holding History

Riggs Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$3.6K – 787
2025
Q2 		$3.6K Hold
100
– – ﹤0.01% 532
2025
Q1 		$3.94K Hold
100
– – ﹤0.01% 338
2024
Q4 		$3.15K Hold
100
– – ﹤0.01% 337
2024
Q3 		$2.34K Hold
100
– – ﹤0.01% 358
2024
Q2 		$1.78K Hold
100
– – ﹤0.01% 380
2024
Q1 		$1.52K Hold
100
– – ﹤0.01% 379
2023
Q4 		$1.71K Hold
100
– – ﹤0.01% 343
2023
Q3 		$836 Buy
+100
New +$1.39K ﹤0.01% 374

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Riggs Asset Management's TGTX Position: Q3 2025 in Review

Riggs Asset Management sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 100 shares — an estimated $3.6K sold.

Riggs Asset Management first reported a position in TGTX in Q3 2023 and held it in 8 quarters. The position peaked at $3.94K in Q1 2025. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Riggs Asset Management reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 100 TG Therapeutics shares in Q3 2025, an estimated $3.6K.
  • Riggs Asset Management first reported a position in TG Therapeutics in Q3 2023 and held it in 8 quarters.
  • Riggs Asset Management's TG Therapeutics position peaked at $3.94K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.